DBV Technologies
Develops epicutaneous immunotherapy (EPIT) patch technology for food allergies.
DBV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417345 (+3 more)
- LEI:
- 969500PVBQFWQKVDMD80
- Country:
- France
- Address:
- 107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
- Sector:
- Manufacturing
Description
DBV Technologies is a clinical-stage biopharmaceutical company developing treatments for food allergies and other immunological diseases. The company's core technology is Viaskin®, a proprietary investigational platform based on epicutaneous immunotherapy (EPIT). This non-invasive patch technology is designed to re-educate the immune system by delivering minimal amounts of antigens through intact skin. DBV's lead product candidate, Viaskin Peanut (DBV712), is in late-stage clinical development for the treatment of peanut allergies in pediatric patients. The development pipeline also includes Viaskin Milk (DBV135) for milk allergies, with the platform holding potential for applications beyond food allergies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-04 22:32 |
Information relative au nombre total des droits de vote et d’actions composant…
|
French | 150.3 KB | ||
| 2025-06-03 22:30 |
DBV Technologies publie un amendement à son Document d’enregistrement universel…
|
French | 178.9 KB | ||
| 2025-06-03 22:30 |
DBV Technologies announces the filing of an addendum to the 2024 Universal Regi…
|
English | 171.4 KB | ||
| 2025-05-15 22:30 |
Assemblée Générale Mixte du 11 juin 2025
|
French | 173.8 KB | ||
| 2025-05-15 22:30 |
Combined General Meeting of June 11, 2025
|
English | 193.4 KB | ||
| 2025-05-06 22:30 |
Information regarding the total number of voting rights and total number of s…
|
English | 95.0 KB | ||
| 2025-05-06 22:30 |
Information relative au nombre total des droits de vote et d’actions composant…
|
French | 100.7 KB | ||
| 2025-05-05 22:30 |
DBV Technologies participera à la conférence Citizens JMP Life Sciences
|
French | 174.6 KB | ||
| 2025-05-05 22:30 |
DBV Technologies to Participate in the Citizens JMP Life Sciences Conference
|
English | 179.4 KB | ||
| 2025-04-30 22:00 |
DBV Technologies publie ses résultats financiers du 1er trimestre 2025
|
French | 188.7 KB | ||
| 2025-04-30 22:00 |
DBV Technologies Reports First Quarter 2025 Financial Results
|
English | 289.7 KB | ||
| 2025-04-15 14:11 |
Franchissement de seuils
|
French | 128.3 KB | ||
| 2025-04-15 14:08 |
Franchissement de seuils
|
French | 222.0 KB | ||
| 2025-04-11 22:30 |
DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistr…
|
French | 244.2 KB | ||
| 2025-04-11 22:30 |
DBV Technologies announces filing of 2024 Annual Report on Form 10-K and Univer…
|
English | 207.0 KB |
Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DBV Technologies
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DBV Technologies via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-09 | N/A | Other | Other | 2,483,161 | 7,449,483.00 EUR |
Peer Companies
